Elastographic ultrasound: an additional image tool in Sjogren's syndrome

被引:25
|
作者
Kimura-Hayama, Eric [1 ]
Criales-Vera, Sergio [1 ]
Azpeitia-Espinosa, Luis [1 ]
Pacheco-Molina, Carlos [2 ]
Reyes, Edgardo [3 ]
Lima, Guadalupe [2 ]
Hernandez-Ramirez, Diego [2 ]
Llorente, Luis [2 ]
Hernandez-Molina, Gabriela [2 ]
机构
[1] Inst Nacl Cardiol Ignacio Chavez, Dept Radiol, Mexico City, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Pathol, Mexico City, DF, Mexico
关键词
elastography; salivary gland; Sjogren's syndrome; ultrasonography; SALIVARY-GLAND ULTRASONOGRAPHY; CLASSIFICATION CRITERIA; DISEASE-ACTIVITY; CXCL13; SONOELASTOGRAPHY; SIALOGRAPHY; DIAGNOSIS;
D O I
10.1111/1756-185X.13292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimTo evaluate the stiffness of parotid and submandibular glands using elastography ultrasound and to correlate it with B-mode ultrasonographical, clinical and serological features, salivary profibrotic and inflammatory chemokines, and salivary gland fibrosis. MethodsWe performed B-mode and elastography ultrasound of major salivary glands of 26 patients with primary Sjogren's syndrome. We registered the shear wave velocity (SWV) and correlated it with the morphologic ultrasonographic changes assessed by the Hocevar scale. We assessed the European League Against Rheumatism (EULAR) Sjogren's Syndrome Disease Activity Index (ESSDAI), EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI), non-stimulated whole salivary flow rate (NSWSF), C3 and C4 levels, anti-Ro/La antibodies, salivary inflammatory (C-X-C motif ligand 13 [CXCL13], CXCL10, CXCL8, C-C motif ligand 2 [CCL2], interleukin 10 [IL-10] and IL-6) and pro-fibrotic (CXCL14, CCL28, tumor necrosis factor-related apoptosis-inducing ligand and transforming growth factor ) chemokines and cytokines and evaluated the presence of fibrosis in the minor salivary gland. ResultsNinety-two percent of patients were women; mean age was 51.111years; median disease duration was 6.1years; 92.3% had oral symptoms and 26.9% fibrosis. The median B-mode score was 22.2 points and the median SWV 2.5m/s (=0.53, P=0.001). The SWV correlated with the NSWSF (=-0.53, P=0.001), ESSDAI (=0.31, P=0.03), glandular ESDDAI domain (=0.36, P=0.02), C4 levels (=-0.32, P=0.04), salivary CXCL13 (=0.29, P=0.03) and CXCL10 (=0.30, P=0.003), but not with age and fibrosis. ConclusionWV correlated with the B-mode ultrasound score, systemic and glandular activity and in a large degree with CXCL10, an inflammatory chemokine, but not with fibrosis. An increased SWV might represent chronic glandular inflammation rather than fibrotic changes in these patients.
引用
收藏
页码:1293 / 1300
页数:8
相关论文
共 50 条
  • [31] Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren's syndrome from secondary Sjogren's syndrome and other sicca syndromes
    Baldini, Chiara
    Giusti, Laura
    Ciregia, Federica
    Da Valle, Ylenia
    Giacomelli, Camillo
    Donadio, Elena
    Sernissi, Francesca
    Bazzichi, Laura
    Giannaccini, Gino
    Bombardieri, Stefano
    Lucacchini, Antonio
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (06)
  • [32] A COMPARISON OF SHEAR WAVE ELASTOGRAPHIC FINDING OF SUBMANDIBULAR GLANDS IN PATIENTS WITH EARLY-STAGE AND NON-SJOGREN'S SYNDROME
    Hashimoto, Naoaki
    Uchiyama, Shozo
    Kitano, Masayasu
    Nakazawa, Takashi
    Iwasaki, Tsuyoshi
    Hashimoto, Takenori
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1722 - 1723
  • [33] Sjogren's syndrome
    Balint, Geza
    Buchanan, W. Watson
    Kean, Colin A.
    Kean, Walter
    Rainsford, K. D.
    INFLAMMOPHARMACOLOGY, 2024, 32 (01) : 37 - 43
  • [34] Sjogren's syndrome
    Sumida, T
    INTERNAL MEDICINE, 1999, 38 (02) : 165 - 168
  • [35] Sjogren's syndrome
    Connolly, MK
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2001, 20 (01) : 46 - 52
  • [36] Sjogren's Syndrome
    Troester, Isabella
    Juelich, Maike
    Voll, Reinhard Edmund
    Kollert, Florian
    AKTUELLE RHEUMATOLOGIE, 2017, 42 (04) : 291 - 300
  • [37] Sjogren's syndrome
    Venables, PJW
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (03): : 313 - 329
  • [38] Sjogren's syndrome
    Sood, S
    Anthony, R
    Pease, CT
    CLINICAL OTOLARYNGOLOGY, 2000, 25 (05) : 350 - 357
  • [39] Sjogren's syndrome
    Soliotis, FC
    Moutsopoulos, HM
    AUTOIMMUNITY, 2004, 37 (04) : 305 - 307
  • [40] Sjogren's syndrome
    Amarasena, Roshan
    Bowman, Simon
    CLINICAL MEDICINE, 2007, 7 (01) : 53 - 56